Home

WILLIAM CROUSE

CIK 1013472 · last filed 2018-03-23

WILLIAM CROUSE is a corporate insider who has filed 17 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing, for MDCO, was dated Mar 23, 2018. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. 12 SEC filings were submitted jointly with JAMES H CAVANAUGH.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

17

Lifetime Open-Market Net

-$2.49M

Filer Profile

Reported Address
BACHNER TALLY POLEVOY & MISHER LLP
380 MADISON AVENUE 18TH FL
NEW YORK, NY 10017
State of Incorporation
DE
Related Filers
JAMES H CAVANAUGH — 12 joint filings, latest 2004-07-09
JOHN W LITTLECHILD — 12 joint filings, latest 2004-07-09
HAROLD R WERNER — 12 joint filings, latest 2004-07-09
AUGUSTINE LAWLOR — 9 joint filings, latest 2004-07-09
Christopher Mirabelli — 9 joint filings, latest 2004-07-09
ERIC AGUIAR — 5 joint filings, latest 2004-07-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MEDICINES CO /DE (MDCO) Delisted Director 60,633 — — -$2.49M 17 2018-03-23

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-03-23 MEDICINES CO /DE (MDCO) Delisted Mixed — -$104.7K EDGAR
2017-05-30 MEDICINES CO /DE (MDCO) Delisted Grant (A) +3,237 $0 EDGAR
2017-05-16 MEDICINES CO /DE (MDCO) Delisted Exer (M) +7,500 $147.0K EDGAR
2016-05-31 MEDICINES CO /DE (MDCO) Delisted Grant (A) +3,426 $0 EDGAR
2016-05-18 MEDICINES CO /DE (MDCO) Delisted Mixed — -$248.3K EDGAR
2015-06-01 MEDICINES CO /DE (MDCO) Delisted Grant (A) +4,531 $0 EDGAR
2015-05-21 MEDICINES CO /DE (MDCO) Delisted Mixed — -$81.2K EDGAR
2013-12-11 MEDICINES CO /DE (MDCO) Delisted Mixed — -$71.3K EDGAR
2013-05-31 MEDICINES CO /DE (MDCO) Delisted Grant (A) +3,849 $0 EDGAR
2013-03-13 MEDICINES CO /DE (MDCO) Delisted Mixed — -$115.4K EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.